ArticleFrontiers in cardiovascular medicine2025
Identification of key genes associated with atrial fibrillation and hypoxia using WGCNA and machine learning technology.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Interpretable machine learning to predict NOAF in ICU patients with CKD: validation in US and Chinese cohorts.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Atrial fibrillation (AF) is among the most prevalent cardiac arrhythmias worldwide, and its incidence is steadily rising due to global aging. Hypoxia, a well-recognized trigger of AF, plays a pivotal role in the onset and progression of AF. However, the molecular mechanisms underlying the interplay between AF and hypoxia remain unclear, and specific biomarkers for this condition are lacking. This study aimed to identify key hypoxia-related genes associated with AF through an integrated bioinformatics approach that combines weighted gene co-expression network analysis (WGCNA) with machine learning (ML) algorithms, and to assess their potential diagnostic significance. Methods: This study employed an integrative approach combining weighted gene co-expression network analysis (WGCNA) and machine learning (ML) to identify key genes associated with AF under hypoxic conditions. AF-related gene expression data were sourced from the Gene Expression Omnibus (GEO) database, and hypoxia-related gene sets from the Molecular Signatures Database (MSigDB) database. WGCNA was employed to identify gene modules associated with AF, which were then intersected with hypoxia-related genes. Candidate hub genes were identified using random forest and least absolute shrinkage and selection operator regression. Their diagnostic performance was evaluated using receiver operating characteristic (ROC) curve analysis. A predictive nomogram was developed, and immune infiltration analysis and gene set enrichment analysis (GSEA) were performed to explore associated biological pathways and alterations in the immune landscape. Results: WGCNA identified 34 gene modules, with the most AF-relevant module comprising 624 genes. Intersection analysis and ML algorithms identified SLC6A6, BGN, and PFKP as key genes. ROC analysis demonstrated strong diagnostic potential. Immune cell profiling showed increased infiltration of M2 macrophages and dendritic cells in AF samples, with significant correlations to the expression of these hub genes. Conclusion: This study identified SLC6A6, BGN, and PFKP as key genes associated with AF under hypoxic conditions and successfully developed a diagnostic model with promising clinical applicability. These genes likely play important roles in hypoxia-mediated AF pathogenesis and are closely associated with immune cell infiltration, providing potential biomarkers for early diagnosis and precision treatment of AF. This study provides novel insights into the molecular mechanisms underlying the interplay between hypoxia and AF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.